from the May 2014 issue

V Wave heart device implanted in first patient

V Wave has developed a shunt for the treatment of congestive heart failure.

V Wave Ltd., which has developed an implantable shunt for the treatment of congestive heart failure, implanted its first shunt in a patient a few weeks ago. The company, founded in 2009, has developed a miniature shunt, which is implanted by catheterization into the left ventricle, to reduce the pressure on the muscle controlling the blood flow between the heart chambers in patients who are frequently hospitalized with heart attacks.

Reprinted from the Israel High-Tech & Investment Report May 2014

Click HERE to request further information.
Click HERE to go BACK.